Skip to main content
. Author manuscript; available in PMC: 2008 May 13.
Published in final edited form as: Eur J Neurosci. 2006 Dec;24(11):3063–3072. doi: 10.1111/j.1460-9568.2006.05197.x

Fig. 3.

Fig. 3

Assessment of composite neuroscore (median +25th and 75th percentile) among the treatment groups. Following injury, brain-injured IgG-treated animals had significantly lower neuroscores than sham-injured IgG-treated animals (**P < 0.01). At 6 weeks post-injury, brain-injured anti-myelin-associated glycoprotein (MAG) monoclonal antibody (mAb)-treated animals had a significantly higher neuroscore than their brain-injured IgG-treated counterparts (#P < 0.05).